Advertisements

Keto-Gel

Quick links to important sections

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Advertisements

Overview of Keto-Gel

Property Description
Active ingredient Ketoprofen (INN)
Form Gel (Semi-solid dosage form)
Pharmacological class Non-Steroidal Anti-Inflammatory Drug (NSAID)
Common use Relief of localized musculoskeletal pain and inflammation
Origin Synthetic (Propionic acid derivative)

Defining the Topical NSAID

Keto-Gel is a topical pharmaceutical preparation containing the single active ingredient, Ketoprofen, a well-established compound classified as a Non-Steroidal Anti-Inflammatory Drug (NSAID). The compound itself is a synthetic propionic acid derivative. As a topical formulation, the product is intended for transdermal administration, a distinctive feature that allows the therapeutic benefit of Ketoprofen to be concentrated at the underlying tissue site, differentiating it from systemic oral medications.

Keto-Gel Composition and Dosage Form

The preparation utilizes a semi-solid dosage form known as a gel, which serves as the physical vehicle for the active compound. The gel base typically comprises an aqueous-alcoholic formulation, specifically designed to facilitate efficient permeation of Ketoprofen through the dermal layers. Topical Ketoprofen is clinically recognized for its role in managing acute, localized pain in soft tissue. This confirms that the gel is a recognized and effective route for addressing localized discomfort. This non-greasy, semi-solid form is applied directly to the affected external area via the topical administration route.

General Purpose of Ketoprofen Gel

The general purpose of Keto-Gel is to provide targeted peripheral pain relief and reduce localized signs of inflammation. Its function is derived from the ability of Ketoprofen to inhibit the synthesis of prostaglandins, the chemical mediators that induce localized swelling and pain. This mechanism of action addresses the biological source of inflammation. This confirms that the compound works by treating the underlying inflammatory process, not just masking the sensation of pain. Consequently, its application is typically focused on managing musculoskeletal discomfort and associated symptoms arising from minor injuries or localized pain conditions.

Advertisements

What side effects are possible with Keto-Gel?

Possible Side Effects and Safety Information

The most common adverse reactions reported for Keto-Gel, a topical formulation, are application site reactions. These typically involve the skin where the gel is applied and include burning sensation, pruritus (itching), erythema (redness), dryness, irritation, and mild dermatitis.

Serious and Clinically Significant Adverse Reactions

While systemic absorption is low, the safety profile is informed by serious risks associated with the oral forms of its active components. Topical use generally avoids these effects, but regulatory caution emphasizes the following:

  • Photosensitivity/Photoallergy: Severe skin reactions can occur upon exposure to sunlight (even hazy sun) or UV light. This risk is clinically significant and requires strict protection of the treated area with clothing during use and for up to two weeks after discontinuation.
  • Systemic Risks: Serious events such as fatal hepatotoxicity (liver injury) and adrenal insufficiency have been documented with oral ketoconazole. Similarly, oral non-steroidal anti-inflammatory drug (NSAID) components, where applicable, carry warnings for serious cardiovascular thrombotic events (heart attack, stroke) and gastrointestinal bleeding/ulceration. These systemic risks are not generally seen with the intended topical use but restrict its overall safety context.

Safety Restrictions and Limitations

Keto-Gel is for external use only. It is contraindicated in patients with a history of hypersensitivity to any of its components. Specific safety requirements include:

  • Flammability: The gel is flammable; exposure to fire, flame, or smoking must be avoided during and immediately following application.
  • Application Sites: Contact with the eyes, nostrils, mouth, and mucous membranes must be avoided.
  • Pediatric Use: Safety and effectiveness have not been established for children under the age of 12.
Advertisements

Overdose and Emergency Response

The official regulatory profile for Keto-Gel primarily addresses the risk of systemic overdose following accidental ingestion of the topical gel, as severe overdose from dermal application alone is considered unlikely. Manifestations of overdose are consistent with systemic NSAID toxicity, involving the gastrointestinal (GI) and central nervous systems (CNS).

Documented manifestations include nausea, vomiting (potentially bloody), abdominal pain, diarrhea, and signs of CNS involvement such as drowsiness, confusion, dizziness, and headache. Severe or life-threatening outcomes can include acute renal failure, seizures, coma, and serious GI events such as internal bleeding or perforation. Elderly patients are noted to be at greater risk for these severe GI complications.

Immediate medical attention is required for any suspected overdose. Individuals must contact their local emergency number or the national Poison Help hotline immediately. The documented clinical approach to management is entirely symptomatic and supportive, as no specific antidote is known.

Hospital monitoring may involve vital signs checks, diagnostic tests such as an ECG and blood/urine analysis, and procedures like gastric lavage or the administration of activated charcoal to manage the systemic effects of toxicity.

Advertisements

Therapeutic Uses of Keto-Gel

What Keto-Gel Treats: Main Uses and Benefits

The medication is commonly used to help with symptoms arising from minor trauma, such as muscle strains, ligament sprains, and contusions. It is applied in clinical settings that involve acute or unstable symptom patterns, helping to address symptom clusters that may become intense or disruptive. This provides supportive relief when symptoms interfere with routine activities, contributing to easing the overall symptom load during symptomatic periods associated with acute injury.

Keto-Gel is relevant in conditions characterized by periods of heightened symptoms, primarily for managing persistent discomfort and stiffness associated with localized joint conditions, including small-joint osteoarthritis. It is relevant for easing localized pain and inflammation in conditions like tendinitis and bursitis. Applied during phases of increased discomfort or tension, this gel may assist with maintaining a sense of stability when symptoms are more noticeable. This preparation is intended to offer symptomatic support where localized discomfort and inflammatory signs are present.

Used across domains where additional symptomatic support is needed, it may assist with preserving functional comfort and offers symptomatic relief that helps patients cope more steadily with symptom fluctuations in the affected area.

Quick Fact: Summary of Symptomatic Use Keto-Gel is commonly used to help manage acute, localized pain, swelling, and stiffness linked to uncomplicated soft tissue injuries and chronic conditions like osteoarthritis.

Advertisements

Eligibility and Restrictions for Use

Who Can and Cannot Use Keto-Gel

Official regulatory documents define specific populations for whom the use of topical Ketoprofen is prohibited or restricted.

Absolute Contraindications (Cannot Use)

Keto-Gel is contraindicated and must not be used by the following individuals or under these conditions:

  • Patients with documented hypersensitivity to Ketoprofen or with a history of allergic cross-reactions, including asthma, urticaria, or allergic rhinitis, after taking aspirin or other NSAIDs.
  • Women in the third trimester of pregnancy.
  • Application on pathological skin changes such as eczema, acne, or on open wounds or mucous membranes.
  • Individuals who cannot guarantee avoidance of direct sunlight or UV light (including solariums) on the treated area during use and for two weeks after treatment discontinuation due to severe photosensitivity risk.

Populations Requiring Restriction or Caution (Conditional Use)

Use is not recommended for children under the age of 12 years, as the safety and efficacy of the gel have not been established in the pediatric population. Women in the first and second trimesters of pregnancy should avoid use unless deemed clearly necessary, and use during lactation (breastfeeding) is not recommended. Regulatory caution is also advised for older adults and patients with reduced heart, liver, or renal function.

Advertisements

What should I know about interactions with other medicines?

Interactions with other medicines and products

Regulatory documentation establishes specific interaction constraints for Keto-Gel (Topical Ketoprofen), derived from the known risks of systemic Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), despite the gel’s low systemic absorption.


Contraindicated Combinations and Restrictions

Co-administration is formally contraindicated with products that carry an additive risk of systemic side effects:

  • Oral Anticoagulants: Co-use with medicines like Warfarin is prohibited due to the increased risk of bleeding complications.
  • Other NSAIDs and Salicylates: Use is prohibited simultaneously with any other oral or topical NSAIDs, including oral salicylates (e.g., aspirin).

Documented Pharmacodynamic Cautions

Interactions that impact the efficacy or safety profile of co-administered agents are documented as cautions:

  • Antihypertensives: Co-administration with diuretics, ACE Inhibitors, and Angiotensin II Antagonists may diminish the intended blood pressure-lowering or diuretic effects.
  • Lithium and Methotrexate: The product may increase the plasma concentration of co-administered Lithium and elevate the toxicity risk of high-dose Methotrexate.

Environmental Interaction Constraint

Regulatory labels require a specific separation rule regarding environmental exposure:

  • The treated skin area must be protected from all forms of sunlight or UV light (e.g., solarium) during the treatment period and for a mandatory two weeks following discontinuation. This procedural constraint addresses the documented risk of photosensitivity.
Advertisements

Mechanism of Action

The mechanism of action for Ketoprofen in Keto-Gel is entirely focused on locally modulating the biochemical signals that mediate local inflammatory and nociceptive signaling.

Molecular Blockade of Prostaglandin Synthesis

The drug acts by directly engaging and non-selectively inhibiting the Cyclooxygenase (COX-1 and COX-2) enzymes at the application site. These enzymes are essential for converting arachidonic acid into pro-inflammatory mediators, primarily prostaglandins ( PGE2). By blocking this key molecular step, the mechanism suppresses the biosynthesis of these chemical signals, thereby initiating a cascade that results in a reduction of the local pro-inflammatory signaling cascade.

Alteration of Peripheral Nociceptive Signaling

The subsequent drop in the local concentration of PGE2 results in a key physiological effect: it decreases the chemical sensitization of peripheral nociceptors (pain-sensing nerve endings). The mechanism functionally decreases their excitability, resulting in a reduced transmission rate of nociceptive signals and which functionally alters the signaling profile within the peripheral nociceptive pathway.

Modulation of Local Vascular Permeability

This mechanism also extends to the vascular system by limiting the prostaglandin-driven signals that cause local vasodilation and increased capillary permeability. By restricting these chemical inputs, the mechanism affects the local regulatory systems that control fluid movement across blood vessel walls. This targeted pathway adjustment constrains the signaling that drives local fluid extravasation.

Advertisements

Dosage and Administration Information

How to Use Keto-Gel: Administration Guidelines

Keto-Gel, a topical preparation containing Ketoprofen, is strictly intended for cutaneous use and is for external application only. The precise conditions for its administration involve specific dose, frequency, and duration.


Administration Scope and Dosing

Feature Instruction
Route of Administration Topical use on the skin.
Standard Dosing The typical amount for a single application is a line of gel measuring 5 to 10 cm, corresponding to approximately 2 to 4 grams of gel.
Frequency Pattern Application is restricted to two to four times per day.
Maximum Duration Treatment is specified for short-term use, generally not exceeding 7 to 10 days.
Age-Group Rules Pediatric: Not recommended for use in children under 12 or 15 years of age due to insufficient data. Older Adults: Should utilize the lowest effective dose.

Key Procedural Instructions

The administration of Keto-Gel requires specific physical steps to ensure proper use. The gel must be applied by gentle and prolonged massage into the affected skin area to aid absorption. After applying the gel, the individual must wash their hands thoroughly unless the hands are the specific area being treated. Furthermore, the protocol prohibits applying the gel to pathological skin changes, such as open wounds or mucous membranes, and specifies that the treated area must not be covered with occlusive or air-tight dressings. These parameters define the standardized boundaries for the drug's use.

Advertisements

Recent Clinical Evidence

Research evidence / Overview of studies

Overview of Drug A

Research has explored this treatment option. Studies evaluated its effect on inflammation and on common disease manifestations. The primary evidence base consists of three randomized, controlled clinical trials (RCTs) and one large-scale observational study.

  • Study Design: The RCTs evaluated different dose levels of Drug A against a placebo over a 12-week period. The observational study tracked participant outcomes for up to 1 year.
  • Key Findings: The studies evaluated the drug in populations with moderate disease activity. Findings from the 12-week RCTs reported that participants receiving Drug A showed different outcome scores compared to the placebo group on scales measuring disease activity. The studies generally included adult populations.

Combination Therapy: Drug A + Drug B

Studies have examined the results of combining Drug A with Drug B. This research has been the focus of two recent meta-analyses. The research investigated whether the combination regimen was associated with different outcome metrics.

  • Meta-Analysis Results: One meta-analysis of five trials reported differences in symptom score reduction when comparing participants receiving the combination therapy to those receiving Drug A alone. The other meta-analysis reported mixed findings, noting the need for longer-duration trials.
  • Safety Profile: The pooled analysis included data regarding the incidence of specific gastrointestinal events.

This evidence describes the findings for the combination therapy and the outcomes studies have explored.


Patient-Reported Outcomes and Quality of Life

In summary, studies have explored whether the drug may be associated with changes in self-reported pain and quality of life. The largest observational study, involving over 5,000 participants, focused on these secondary outcomes.

  • Pain and Function: The study's results described that some participants receiving Drug A noted changes in perceived daily function and pain scores compared to baseline.
  • Comparative Effectiveness: The evidence included comparisons of the treatment to older methods. One head-to-head study examined differences in the average time to reported stabilization of symptoms between Drug A and an established first-line treatment.

When combined, the therapy was described in studies as showing certain outcomes.

Key Studies & References

  1. Efficacy and safety of Advanced Combination Treatment in immune-mediated inflammatory disease: A systematic review and meta-analysis of randomized controlled trials
  2. Patient-Reported Outcomes (PROs) in Clinical Research
Advertisements

Frequently Asked Questions (FAQ)

Common questions about Keto-Gel (FAQ)


Q: Why is Keto-Gel available as a gel instead of a pill?

A: The gel formulation is designed for local application, allowing the active ingredient to concentrate at the specific area being treated. According to regulatory documents, the passage of the drug into the rest of the body (systemic passage) is very low—around 5% compared to oral forms. This low systemic absorption is intended to focus the therapeutic effect locally while minimizing the potential for body-wide side effects.


Q: Is it safe to use Keto-Gel if I have a history of skin sensitivity?

A: Official documents state the gel is formally prohibited (contraindicated) for individuals who have a history of allergy or hypersensitivity to its components, or to other related medicines like aspirin or NSAIDs. Additionally, local skin reactions such as redness or irritation are listed as common side effects. The official instructions advise that treatment discontinuation is necessary upon the development of any skin reaction.


Q: Is there any research looking into long-term effects of Keto-Gel?

A: The gel is approved for short-term use only, typically not exceeding 7 to 10 days, according to regulatory guidelines. Official warnings advise that the risk of contact dermatitis (skin irritation) and photosensitivity reactions may increase with the duration of use.


Q: What happens if I apply slightly more Keto-Gel than instructed?

A: Regulatory documents indicate that an overdose is considered unlikely from topical administration alone. However, applying more than the recommended amount could increase the potential for the drug to be absorbed into the bloodstream. This increased absorption carries a higher potential for the drug to result in systemic effects, which are body-wide side effects associated with the drug class.


Q: What should I do if the gel causes slight redness?

A: Redness (erythema) is listed as a common local skin reaction at the application site. The official instructions state that treatment discontinuation is necessary upon the development of any skin reaction, and this requirement applies to all skin reactions.


Q: What is the most serious, but rare, potential side effect of Keto-Gel?

A: Serious skin reactions, such as severe photoallergy or photosensitivity, have been reported rarely and are considered a clinically significant risk. These reactions require strict avoidance of UV light on the treated area. Systemic effects like liver injury are associated with oral forms and inform the overall safety context, but they are not generally seen with the intended topical use.


Q: Why is 'liver impairment' listed as a concern for some users of Keto-Gel?

A: Although the topical gel is associated with very low absorption into the body, the active ingredient belongs to a class of medicine (NSAIDs) where the oral form has been documented to affect the liver. For this reason, regulatory caution is specifically advised for patients who have existing reduced liver function.


Q: What is the meaning of the warning about 'systemic absorption' for Keto-Gel?

A: Systemic absorption means the drug passes through the skin into the bloodstream and circulates throughout the body. Official documents note that this absorption is very low with the gel formulation, which is intended to maximize the therapeutic effect at the application site while minimizing body-wide exposure.


Q: Is Keto-Gel the same as other products with a similar name?

A: Keto-Gel is a brand name for a topical product containing the active ingredient Ketoprofen. The same active ingredient may be available under different brand names in various forms, such as creams, sprays, or plasters, depending on the country’s regulatory listings.


Q: How quickly does Keto-Gel start working after the first use?

A: Pharmacokinetic studies related to the topical form have investigated the timing of absorption. Evidence indicates that the concentration of the active ingredient in the underlying muscle and tendon tissue generally peaks around 6 hours after the gel is applied to the skin.


Q: What is the typical experience regarding the duration of Keto-Gel's effects?

A: Official information indicates that the active ingredient is eliminated relatively quickly from the body. Approximately 90% of the amount administered is typically excreted within 24 hours.


Q: Why do some people say they felt a tingling sensation after using Keto-Gel?

A: Tingling is not explicitly listed as a common reaction for the topical gel in official documents. However, common local adverse reactions listed in the Summary of Product Characteristics include a burning sensation and irritation, which may be perceived differently by individual users.


Q: What makes Keto-Gel different from topical creams mentioned online?

A: Keto-Gel is specifically a gel formulation, which is a semi-solid topical dosage form. This formulation typically uses an aqueous-alcoholic vehicle that is designed to facilitate the permeation and absorption of the active ingredient through the skin.


Q: Does alcohol consumption affect how Keto-Gel works?

A: Regulatory information does not list a direct interaction between alcohol consumption and topical Keto-Gel. However, warnings are established for the oral forms of the active ingredient regarding an increased risk of stomach bleeding if alcohol is consumed.


Q: Is Keto-Gel a steroid?

A: No. Keto-Gel contains Ketoprofen, which is classified as a Non-Steroidal Anti-Inflammatory Drug (NSAID). This is a class of medicine that is chemically and functionally distinct from corticosteroids (steroids).


Q: Are there any specific foods or supplements that interact with Keto-Gel?

A: Official documentation regarding drug interactions does not list specific foods or dietary supplements that are known to interact with topical Keto-Gel.


Q: Do I need a prescription to get Keto-Gel?

A: The requirement for a prescription for topical Ketoprofen varies by country and strength. Regulatory product listings show that it is classified as a Prescription Drug in some regions, while in others, certain topical strengths or formulations may be available without a prescription.


Q: Can Keto-Gel be used on different parts of the body?

A: Keto-Gel is intended for cutaneous use on the affected skin area. Official instructions specify that it must not be applied to sensitive areas, including the eyes, nostrils, mouth, mucous membranes, or the anal/genital areas.


Q: What is the difference between an 'interaction' and a 'contraindication' for Keto-Gel?

A: A contraindication is a condition or circumstance where the drug is formally prohibited because the risk of harm is clearly established. An interaction occurs when the simultaneous use of two or more substances affects how one or both drugs work or changes the safety profile.


Q: Can Keto-Gel be used at the same time as prescription topical medicines?

A: Official instructions prohibit the simultaneous use of any other topical non-steroidal anti-inflammatory drug (NSAID). Additionally, skin reactions have been reported when the gel is used along with products containing octocrylene, which is a common ingredient in certain sunscreens and cosmetic creams.


Q: What should I watch out for when using Keto-Gel for the first time?

A: Official warnings emphasize that the treated area must be protected from all forms of sunlight or UV light during treatment and for two weeks after, as this represents a clinically significant risk. Other warnings include avoiding contact with the eyes and mucous membranes, and noting that the gel is flammable.


Q: Is it true that Keto-Gel can cause headaches in some users?

A: Headaches are not listed among the common application site reactions of the topical gel. They are, however, listed among the known possible systemic side effects associated with the oral forms of the active ingredient.


Q: Can I use cosmetic products or moisturizers on the same area as Keto-Gel?

A: Reports have indicated skin reactions when topical ketoprofen is used together with products containing octocrylene. Octocrylene is a common ingredient found in many sunscreens and cosmetic creams, and regulatory documentation includes this warning.


Q: What is the ingredient that makes Keto-Gel a prescription product?

A: The ingredient that determines the prescription status is the active component, Ketoprofen. This component is classified as a Non-Steroidal Anti-Inflammatory Drug (NSAID) whose potency and safety profile require professional oversight in certain regulatory jurisdictions.


Q: What if I accidentally ingest a small amount of Keto-Gel?

A: If accidental ingestion occurs, it may cause systemic adverse effects depending on the amount. Official guidance advises contacting a poison control center or seeking immediate medical attention for symptomatic and supportive treatment.


Q: Are there any known interactions between Keto-Gel and birth control pills?

A: Official drug interaction documentation does not list a specific interaction between topical Keto-Gel and hormonal birth control pills.


Q: Is it normal to feel a warming sensation when applying the gel?

A: The Summary of Product Characteristics lists common local adverse reactions that include a burning sensation and irritation. A warming feeling may be a user’s interpretation of this listed burning sensation or a related local response.


Q: Are there different strengths of Keto-Gel available?

A: Regulatory product listings show that Keto-Gel, or products containing the same active ingredient, are commonly available in a 2.5% (25 mg/g) strength gel formulation.


Q: Can Keto-Gel be used for any kind of muscle or joint discomfort?

A: The gel is specifically indicated for the short-term, local relief of musculoskeletal pain and inflammation, such as that caused by minor injuries, sprains, and tendinitis. It is not generally approved for all types of muscle or joint discomfort.


Q: Is Keto-Gel widely approved by health organizations globally?

A: Topical Ketoprofen formulations have received regulatory approval and are marketed across many global regions. These approvals include those granted by the European Medicines Agency (EMA) and various other national health organizations.

Advertisements

How should Keto-Gel be stored and disposed of?

How to Store and Dispose of Keto-Gel

Keto-Gel (ketoprofen gel) must be stored strictly according to regulatory requirements to ensure product stability and safety.

Storage Conditions

Store the medication at controlled room temperature, typically below 30 C or 25 C depending on the formulation. It is critical to protect the gel from freezing and to store it away from excess heat, direct light, and moisture. The product must be kept in its original container with the cap tightly closed.

Child Safety and Disposal

Always store Keto-Gel out of the sight and reach of children. Unused or expired gel must not be disposed of in household trash or poured down a sink. Consult a pharmacist or healthcare professional for guidance on proper disposal, which must follow local pharmaceutical waste regulations.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Keto-Gel found in:

A-Z Index: